ABVC vs PLTR · rev $509.6K vs P/E 584, rev $4.48B
ABVC Biopharma Inc (ABVC) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
ABVC currently screens at market cap $35.9M. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the ABVC and PLTR stock pages for the full models.
Not investment advice.